🔗 Share this article

An underground market for unlicensed slimming medications is propelled by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Investigational Drug Acquiring Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Followers are encouraged to message these profiles directly for source information, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing market exists on messaging services, where communities with numerous of members share comparison photos, injection guides and assertions of rapid UK delivery. Vendors market the drug there before redirecting buyers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Experts Express Worries

Nevertheless, physicians and pharmacists have cautions that the distribution of what remains an unapproved medication in the UK is a cause for concern and could result in individuals administering substances of unknown origin.

Several experts said the popularity for the experimental drug could be linked to the rising price of licensed slimming products such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still violate medicines, advertising, and consumer laws, risking fines, prosecution or prison.

Service Reaction and Material Removal

Based on TikTok, the platform has taken down violative material and banned related keywords and search suggestions. The company stated it was dedicated to maintaining the platform safe and allocating resources in enhancing compliance measures.

Online Trading Operations

Investigations also found communities with up to nine thousand participants selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays groups with numerous of members, populated with photos of slimming results, glowing reviews and detailed guides for preparing or injecting at home.

Within minutes of entering one group, a vendor posted contact information, where the majority of transactions take place. The vendor sent an instruction manual and promised delivery within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None asked about body mass, health issues or previous experience.

Item Details and Pricing

Inside these groups, posts show dark colored parcels with postal service stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When asked how much time a pen should be used, vendors give conflicting answers varying between a several days to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for the messaging service stated it actively moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting substances they cannot confirm. Even if the research behind this drug is valid, these digital versions may not include what they claim,” said Jason Murphy, the head of pharmacy at Chemist4U.

A medical professional of an online medical service linked the increase in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But fake injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.

Her staff has already seen individuals harmed by self-injection from unverified sources. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These substances could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a company experimental product not yet approved … may expose patients to potentially significant health risks”.